Congenital Portosystemic Shunt (CPSS) is a rare condition important by the multiplicity and severity of associated complications.
CPSS is venous anomaly in which blood coming from the intestines only partially passes through the liver.
This leads to the accumulation of potentially toxic factors that cause systemic effects.
Complications vary among the individuals, and currently, it is challenging to predict which individuals will develop severe complications.
The IRCPSS registry is established with the aim of centralizing detailed clinical follow-up and biological information from participants around the world who suffer from Congenital Portosystemic Shunt (CPSS). A multidisciplinary consortium of experts is collaborating to enhance our understanding of the prevalence, natural history, individual risks, and physiopathology of the disease through the IRCPSS registry.
Who can participate
Inclusion Criteria:
Individual with CPSS
Exclusion Criteria:
Secondary shunt without evidence of congenital shunt
Locations
16
Australia (1)
Royal Children's Hospital Melbourne
Parkville , Victoria
Belgium (1)
Universitary Clinics Saint-Luc, UCL
Brussels
Canada (1)
The Hospital for Sick Children
Toronto , Ontario
France (1)
Beaujon University Hospital
Clichy
Germany (1)
Hannover Medical School
Hanover
Hungary (1)
First Department of Pediatrics, Semmelweis University